Showing results (81-90 of 109) with videos related to
Sort By:
Pageof 11
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2010
The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancerGary J R Cook, Ram Venkitaraman, Aslam S Sohaib, et al.EJNMMI Research|May 17, 2023
[<sup>99m</sup>Tc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expressionMuhummad Sohaib Nazir, Daniel Johnathan Hughes, Gitasha Chand, et al.Nature Reviews. Urology|November 10, 2025
Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancerSola Adeleke, Joao R Galante, Yishen Wang, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2025
Is Long-Axial-Field-of-View PET/CT Cost-Effective? An International Health-Economic AnalysisIan Alberts, Stuart More, Karen Knapp, et al.JTO Clinical and Research Reports|September 9, 2022
Role of 3'-Deoxy-3'-[<sup>18</sup>F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With PegargiminaseTeresa A Szyszko, Joel T Dunn, Melissa M Phillips, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2020
Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized TrialIe-Wen Sim, Gelsomina L Borromeo, Claudine Tsao, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2026
Imaging xCT with Immuno-PET in Therapy-Resistant Non-Small Cell Lung CancerAbigail R Barber, Richard S Edwards, Sofia N Dos Santos, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 25, 2019
The management impact of <sup>68</sup>gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (<sup>68</sup>Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancerMeghana Kulkarni, Simon Hughes, Andrew Mallia, et al.Journal of Thoracic Imaging|July 13, 2015
Imaging Tumor Response and Tumoral Heterogeneity in Non-Small Cell Lung Cancer Treated With Antiangiogenic Therapy: Comparison of the Prognostic Ability of RECIST 1.1, an Alternate Method (Crabb), and Image Heterogeneity AnalysisConnie Yip, Nunzia Tacelli, Martine Remy-Jardin, et al.Radiology|March 31, 2026
Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung CancerRobert O'Shea, Carolyn Horst, Thubeena Manickavasagar, et al.Pageof 11